Lanean...

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?

During the clinical trial development of directly acting antivirals (DAAs), evidence regarding the treatment efficacy in chronic hepatitis C patients with hepatocellular carcinoma (HCC) was scarce because these patients have always been excluded. Apart from the clinical trials, more HCC patients are...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Mol Hepatol
Egile Nagusiak: Huang, Chung-Feng, Yu, Ming-Lung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association for the Study of the Liver 2019
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6589855/
https://ncbi.nlm.nih.gov/pubmed/30739433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2018.1014
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!